Psilocybin-Induced Mystical-Type experiences are related to persisting positive effects: a quantitative and qualitative report DEW McCulloch, MZ Grzywacz, MK Madsen, PS Jensen, B Ozenne, ... Frontiers in pharmacology 13, 2022 | 71 | 2022 |
Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses DEW McCulloch, GM Knudsen, FS Barrett, MK Doss, RL Carhart-Harris, ... Neuroscience & Biobehavioral Reviews, 104689, 2022 | 70 | 2022 |
Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals DEW McCulloch, MK Madsen, DS Stenbaek, S Kristiansen, B Ozenne, ... Journal of Psychopharmacology, 2021 | 52 | 2021 |
The therapeutic potential of psychedelics: the European regulatory perspective F Butlen-Ducuing, D McCulloch, M Haberkamp, T Mattila, ... The Lancet, 2023 | 13 | 2023 |
Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin DJ Londesbrough, C Brown, JS Northen, G Moore, HK Patil, DE Nichols, ... US Patent 11,564,935, 2023 | 8 | 2023 |
Navigating the chaos of psychedelic neuroimaging: A multi-metric evaluation of acute psilocybin effects on brain entropy DEW McCulloch, AS Olsen, B Ozenne, DS Stenbaek, S Armand, ... medRxiv, 2023.07. 03.23292164, 2023 | 8 | 2023 |
Effects of an oral contraceptive on dynamic brain states and network modularity in a serial single-subject study KHR Jensen, DEW McCulloch, AS Olsen, SEP Bruzzone, SV Larsen, ... Frontiers in Neuroscience 16, 855582, 2022 | 6 | 2022 |
Methods of treating neurocognitive disorders, chronic pain and reducing inflammation DJ Londesbrough, C Brown, JS Northen, G Moore, HK Patil, DE Nichols, ... | 5 | 2022 |
Treatment of depression and other various disorders with psilocybin DJ Londesbrough, C Brown, JS Northen, G Moore, HK Patil, DE Nichols, ... | 4 | 2022 |
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects DEW McCulloch, ME Liechti, KPC Kuypers, D Nutt, J Lundberg, ... Neuroscience Applied, 103938, 2024 | 1 | 2024 |
Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms DEW McCulloch, JP Lopez, C Dalla, E Castrén, D Erritzoe, VG Frokjaer, ... Neuroscience Applied, 103929, 2023 | 1 | 2023 |
A multi-metric evaluation of psilocybin effects on functional brain entropy in healthy volunteers DEW McCulloch, AS Olsen, DS Stenbæk, S Armand, MK Madsen, ... Neuroscience Applied 2, 103723, 2023 | | 2023 |
Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labelling K Larsen, U Lindberg, B Ozenne, DEW McCulloch, S Armand, ... Neuroscience Applied 2, 102665, 2023 | | 2023 |
P. 0593 Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals D Mcculloch, MK Madsen, DS Stenbæk, S Kristiansen, B Ozenne, ... European Neuropsychopharmacology 53, S433-S434, 2021 | | 2021 |
Methods of treating neurocognitive disorders, chronic pain and reducing inflammation DJ Londesbrough, C Brown, JS Northen, G Moore, HK Patil, DE Nichols, ... | | 2020 |
Treatment of depression and other various disorders with psilocybin DJ Londesbrough, C Brown, JS Northen, G Moore, HK Patil, DE Nichols, ... | | 2020 |
Neuroscience Applied E Drummond, W McCulloch, ME Liechti, KPC Kuypers, D Nutt, J Lundberg, ... | | |
Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humans K Larsen, DE McCulloch, B Ozenne, U Lindberg, S Armand, MK Madsen, ... | | |